Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)

被引：0
|
作者：
Gauler, T. [1 ]
Nel, I. [1 ]
Bublitz, K. [1 ]
Lazaridis, L. [1 ]
Schuler, M. [1 ]
Hoffmann, A-C [1 ]
机构：
[1] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Circulating Tumor Cell Composition in Renal Cell Carcinoma
    Nel, Ivonne
    Gauler, Thomas C.
    Bublitz, Kira
    Lazaridis, Lazaros
    Goergens, Andre
    Giebel, Bernd
    Schuler, Martin
    Hoffmann, Andreas-Claudius
    [J]. PLOS ONE, 2016, 11 (04):
  • [2] Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
    Zengin, Zeynep Busra
    Dizman, Nazli
    Salgia, Nicholas
    Jones, Jeremy
    Zhang, Jingbo
    Liu, Yunchao
    Xu, Bing
    Li, Fuwei
    Wang, Yan
    Li, Mengjian
    Du, Rong
    Zhou, Ye
    Hsu, Joann
    Salgia, Meghan
    Yang, Lixin
    Pal, Sumanta K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden
    Maia, Manuel Caitano
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Hsu, Joann
    Jones, Jeremy
    Choueiri, Toni K.
    Sonpavde, Guru
    Lannnan, Richard B.
    Banks, Kimberly
    Pal, Sumanta K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Gene expression profile of circulating tumor cells (CTCs) in clear cell metastatic renal cell carcinoma (mRCC)
    Iacovelli, R.
    Nicolazzo, C.
    Petracca, A.
    Risi, E.
    Cortesi, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] Tumor markers for renal cell carcinoma
    Oosterwijk, E
    [J]. JOURNAL OF UROLOGY, 2005, 173 (06): : 1847 - 1847
  • [6] Circulating tumor cells status in metastatic renal cell carcinoma (mRCC) after metastasectomy (RESORT trial)
    Verzoni, E.
    Grassi, P.
    Cappelleti, V.
    Maggi, C.
    Montone, R.
    de Braud, F.
    Procopio, G.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 63 - 63
  • [7] Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).
    Zurita, Amado J.
    Danziger, Natalie
    Scott, Takara
    Gjoerup, Ole
    Zhong, Lei
    Tukachinsky, Hanna
    Ross, Jeffrey S.
    Graf, Ryon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 455 - 455
  • [8] Radiotherapy of metastasized renal cell carcinoma
    van Oorschot, B.
    Polat, B.
    Rades, D.
    [J]. ONKOLOGE, 2015, 21 (01): : 50 - 54
  • [9] Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
    Hahn, Andrew W.
    Nussenzveig, Roberto H.
    Maughan, Benjamin L.
    Agarwal, Neeraj
    [J]. KIDNEY CANCER, 2019, 3 (01) : 7 - 13
  • [10] Tumor antigens and markers in renal cell carcinoma
    Mulders, P
    Bleumer, I
    Oosterwijk, E
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (03) : 455 - +
12345